Intrathecal Vincristine: Fatal Myeloencephalopathy Despite Cerebrospinal Fluid Perfusion
- 8 January 2002
- journal article
- case report
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 40 (5) , 557-561
Abstract
Background: Vincristine, an antineoplastic agent, must never be injected intrathecally because of its devastating neurotoxic effects, which are usually fatal. We report a case of fatal myeloencepha...Keywords
This publication has 25 references indexed in Scilit:
- Prolonged Survival Following the Inadvertent Intrathecal Administration of VincristineClinical Neuropharmacology, 1991
- Treatment of Inadvertent Intrathecal Injection of VincristineNew England Journal of Medicine, 1989
- Intrathecal vincristine. Report of a fatal case despite CNS washoutCancer, 1983
- Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic errorCancer, 1983
- Accidental intrathecal vincristine administrationJournal of Neurology, 1982
- Fatal myeloencephalopathy caused by intrathecal vincristineNeurology, 1980
- The Mode of Action of Vinca AlkaloidsOncology, 1980
- Accidental intrathecal administration of vincristineMedical and Pediatric Oncology, 1978
- Vincristine NeurotoxicityAnnals of Internal Medicine, 1974
- Vincristine neuropathy: an electrophysiological and histological study.Journal of Neurology, Neurosurgery & Psychiatry, 1969